SCHEMBL547054

SCHEMBL547054

CC(=O)C(O)[C@H]1O[C@H](Br)[C@@](O)(C(C)=O)[C@](O)(C(C)=O)[C@]1(O)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8355186 1.00
SCHEMBL9346141 1.00
SCHEMBL6705836 1.00
SCHEMBL7065528 1.00
SCHEMBL5902150 1.00
SCHEMBL2043596 1.00
SCHEMBL11103581 0.89
SCHEMBL9725008 0.88
SCHEMBL9475120 0.85
SCHEMBL9712160 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114605343-B Fluorescent group LAN-OH, fluorescent sensor LAN-beta gal, preparation method and application thereof 吉林大学 2022-11-18 CN claimed
CN-114605343-A Fluorescent group LAN-OH, fluorescent sensor LAN-beta gal, preparation method and application thereof 吉林大学 2022-06-10 CN claimed
EP-0044188-B1 SYNTHESIS OF TUMOR ANTIGENIC DETERMINANT CHEMBIOMED LTD. (CA) 1986-05-28 EP claimed
EP-0044188-A2 Synthesis of tumor antigenic determinant CHEMBIOMED LTD. (CA) 1982-01-20 EP claimed
WO-2024143491-A1 COMPOUND EMITTING LIGHT UNDER SPECIFIC CONDITIONS, AND METHOD FOR DETECTING CANCER STEM CELLS USING SAME 国立大学法人京都大学 2024-07-04 WO disclosed
CN-114605343-B Fluorescent group LAN-OH, fluorescent sensor LAN-beta gal, preparation method and application thereof 吉林大学 2022-11-18 CN disclosed
CN-114605343-A Fluorescent group LAN-OH, fluorescent sensor LAN-beta gal, preparation method and application thereof 吉林大学 2022-06-10 CN disclosed
US-20210102949-A1 Organotellurium Compounds, Compositions and Methods of Use Thereof UNIVERSITY HEALTH NETWORK (CA) 2021-04-08 US disclosed
US-10816552-B2 Organotellurium compounds, compositions and methods of use thereof THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2020-10-27 US disclosed
US-20190250165-A1 Organotellurium Compounds, Compositions and Methods of Use Thereof THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2019-08-15 US disclosed
US-10222380-B2 Organotellurium compounds, compositions and methods of use thereof THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2019-03-05 US disclosed
US-20170269094-A1 ORGANOTELLURIUM COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF UNIVERSITY HEALTH NETWORK (CA) 2017-09-21 US disclosed
US-5252462-A Enzyme activity determinations method characterized by the using of substrates whose fluorescent properties differs those of the converted products PHARMACIA AB (SE) 1993-10-12 US disclosed
US-5034317-A Immunoassay, enzyme amplification systems and drug release; based on an intramolecular displacement reaction mechanism for the release of a specific ligand POLAROID CORPORATION (US) 1991-07-23 US disclosed
US-5013827-A Useful In Immunoassays BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1991-05-07 US disclosed
EP-0379716-A1 Chemiluminescent 1,2-dioxetane compounds TROPIX, INC. (US) 1990-08-01 EP disclosed
EP-0374221-A1 Method for enzyme activity determination characterized by the use of substrates which fluorescent properties differ from those of the converted products. PHARMACIA AB (SE) 1990-06-27 EP disclosed
WO-1989010975-A1 ENZYME ACTIVITY DETERMINATIONS METHOD CHARACTERIZED BY THE USING OF SUBSTRATES WHOSE FLUORESCENT PROPERTIES DIFFERS THOSE OF THE CONVERTED PRODUCTS PHARMACIA AB (SE) 1989-11-16 WO disclosed
EP-0299985-A1 ENZYME CONTROLLED RELEASE SYSTEM. POLAROID CORP (US) 1989-01-25 EP disclosed
WO-1988005827-A1 ENZYME CONTROLLED RELEASE SYSTEM AND ORGANIC CONJUGATE REACTANT POLAROID CORPORATION (US) 1988-08-11 WO disclosed